Analysis of factors affecting enoxaparin effectiveness on coagulation, inflammation, and clinical outcomes in patients with COVID-19
Context: Hypercoagulopathy is a COVID-19 extra-pulmonary manifestation has drawn the attention of the scientists due to its risk of thromboembolism. Enoxaparin is an anticoagulant used to prevent hypercoagulopathy. Many factors have been associated with enoxaparin effectiveness. Aims: To analyze fac...
Saved in:
Main Authors: | Budi Suprapti (Author), Liana Debora (Author), Rifdah Atikah Safitri (Author), Dewi Kusumawati (Author), Arina Dery Puspitasari (Author) |
---|---|
Format: | Book |
Published: |
GarVal Editorial Ltda.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enoxaparin-Induced DRESS Syndrome
by: Sophie Ronceray, et al.
Published: (2012) -
Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis
by: Reem Ali Shaker, et al.
Published: (2018) -
Enoxaparin Utilization Evaluation and Its Clinical and Laboratory Outcomes in Pediatric Patients in a Children's Teaching Hospital
by: Uldooz Samadi Bahrami, et al.
Published: (2020) -
Bullous hemorrhagic dermatosis induced by enoxaparin
by: Isa An, et al.
Published: (2017) -
THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017)